Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Retinoids in cancer therapy and chemoprevention: promise meets resistance

Abstract

Retinoids (natural and synthetic derivatives of vitamin A) signal potent differentiation and growth-suppressive effects in diverse normal, premalignant, and malignant cells. A strong rationale exists for the use of retinoids in cancer treatment and chemoprevention based on preclinical, epidemiological, and early clinical findings. Despite the success of all-trans-retinoic acid (RA)-based differentiation therapy in acute promyelocytic leukemia (APL), the broad promise of retinoids in the clinic has not yet been realized. In addition to the expected limited activity of any single therapeutic agent, translation of retinoid activities from the laboratory to the clinic has met with intrinsic or acquired retinoid resistance. Evidence suggests that solid tumors develop intrinsic resistance to retinoids during carcinogenesis. In contrast, relapse of APL is often associated with acquired resistance to retinoid maturation induction. This review discusses what is known about retinoid resistance mechanisms in cancer therapy and chemoprevention. Strategies to overcome this resistance will be discussed, including combination therapy with other differentiation-inducing, cytotoxic or chromatin-remodeling agents, as well as the use of receptor-selective and nonclassical retinoids. Opportunities exist in the post-genomic era to bypass resistance to classical retinoids by identifying target genes and associated pathways that directly mediate the antineoplastic effects of retinoids. In this regard, the retinoids are useful pharmacological tools to reveal important pathways targeted in cancer therapy and chemoprevention.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  • Albanell J, Han W, Mellado B, Gunawardane R, Scher HI, Dmi-trovsky E and Moore MA . (1996). Cancer Res., 56, 1503–1508.

  • Bender CM, Pao MM and Jones PA . (1998). Cancer Res., 58, 95–101.

  • Benedetti L, Levin AA, Scicchitano BM, Grignani F, Allenby G, Diverio D, Lo Coco F, Avvisati G, Ruthardt M, Adamo S, Pelicci PG and Nervi C . (1997). Blood, 90, 1175–1185.

  • Berard J, Laboune F, Mukuna M, Masse S, Kothary R and Bradley WE . (1996). FASEB J., 10, 1091–1097.

  • Berg WJ, Divgi CR, Nanus DM and Motzer RJ . (2000). Semin. Oncol., 27, 234–239.

  • Berg WJ, Nanus DM, Leung A, Brown KT, Hutchinson B, Mazumdar M, Xu XC, Lotan R, Reuter VE and Motzer RJ . (1999). Clin. Cancer Res., 5, 1671–1675.

  • Blaner WS, Piantedosi R, Sykes A and Vogel S . (1999). Retinoids: Handbook of Experimental Pharmacology. Nau H and Blaner WS (eds), Vol. 139. Springer: Berlin, pp. 117–152.

    Book  Google Scholar 

  • Brabender J, Danenberg KD, Metzger R, Schneider PM, Lord RV, Groshen S, Tsao-Wei DD, Park J, Salonga D, Holscher AH and Danenberg PV . (2002). Clin. Cancer Res., 8, 438–443.

  • Brigati C, Nobile L, Fugazza G, Zohouri M, Gallagher R and Cannizzaro L . (1999). Leuk. Res., 23, 105–113.

  • Brown D, Kogan S, Lagasse E, Weissman I, Alcalay M, Pelicci PG, Atwater S and Bishop JM . (1997). Proc. Natl. Acad. Sci. USA, 94, 2551–2556.

  • Budhu AS and Noy N . (2002). Mol. Cell. Biol., 22, 2632–2641.

  • Calleja EM and Warrell Jr RP . (2000). Curr. Oncol. Rep., 2, 519–523.

  • Carapeti M, Aguiar RC, Goldman JM and Cross NC . (1998). Blood, 91, 3127–3133.

  • Castillo L, Milano G, Santini J, Demard F and Pierrefite V . (1997). Clin. Cancer Res., 3, 2137–2142.

  • Cheer SM and Foster RH . (2000). Am. J. Clin. Dermatol., 1, 307–314.

  • Chen JD and Evans RM . (1995). Nature, 377, 454–457.

  • Christman JK . (2002). Oncogene, 21, 5483–5495.

  • Collins SJ, Robertson KA and Mueller L . (1990). Mol. Cell. Biol., 10, 2154–2163.

  • Conley B, O'Shaughnessy J, Prindiville S, Lawrence J, Chow C, Jones E, Merino MJ, Kaiser-Kupfer MI, Caruso RC, Podgor M, Goldspiel B, Venzon D, Danforth D, Wu S, Noone M, Goldstein J, Cowan KH and Zujewski J . (2000). J. Clin. Oncol., 18, 275–283.

  • Cornic M, Delva L, Castaigne S, Lefebvre P, Balitrand N, Degos L and Chomienne C . (1994). Leukemia, 8, 914–917.

  • Cote S and Momparler RL . (1997). Anticancer Drugs, 8, 56–61.

  • Cote S, Sinnett D and Momparler RL . (1998). Anticancer Drugs, 9, 743–750.

  • Curtin JC, Dragnev KH, Sekula D, Christie AJ, Dmitrovsky E and Spinella MJ . (2001). Oncogene, 20, 2559–2569.

  • Delva L, Cornic M, Balitrand N, Guidez F, Miclea JM, Delmer A, Teillet F, Fenaux P, Castaigne S, Degos L and Chomienne C . (1993). Blood, 82, 2175–2181.

  • Demary K, Wong L, Liou JS, Faller DV and Spanjaard RA . (2001). Endocrinology, 142, 2600–2605.

  • Dermime S, Grignani F, Clerici M, Nervi C, Sozzi G, Talamo GP, Marchesi E, Formelli F, Parmiani G, Pelicci PG and Gambacorti-Passerini C . (1993). Blood, 82, 1573–1577.

  • Dimberg A, Bahram F, Karlberg I, Larsson LG, Nilsson K and Oberg F . (2002). Blood, 99, 2199–2206.

  • Dokmanovic M, Chang BD, Fang J and Roninson IB . (2002). Cancer Biol. Ther., 1, 24–27.

  • Dragnev KH, Freemantle SJ, Spinella MJ and Dmitrovsky E . (2001). Ann. N.Y. Acad. Sci., 952, 13–22.

  • Early E, Moore MA, Kakizuka A, Nason-Burchenal K, Martin P, Evans RM and Dmitrovsky E . (1996). Proc. Natl. Acad. Sci. USA, 93, 7900–7904.

  • Esteller M, Guo M, Moreno V, Peinado MA, Capella G, Galm O, Baylin SB and Herman JG . (2002). Cancer Res., 62, 5902–5905.

  • Fanelli M, Minucci S, Gelmetti V, Nervi C, Gambacorti-Passerini C and Pelicci PG . (1999). Blood, 93, 1477–1481.

  • Ferrara FF, Fazi F, Bianchini A, Padula F, Gelmetti V, Minucci S, Mancini M, Pelicci PG, Lo Coco F and Nervi C . (2001). Cancer Res., 61, 2–7.

  • Fondell JD, Ge H and Roeder RG . (1996). Proc. Natl. Acad. Sci. USA, 93, 8329–8333.

  • Freemantle SJ, Kerley JS, Olsen SL, Gross RH and Spinella MJ . (2002). Oncogene, 21, 2880–2889.

  • Gallagher RE . (2002). Leukemia, 16, 1940–1958.

  • Grignani F, De Matteis S, Nervi C, Tomassoni L, Gelmetti V, Cioce M, Fanelli M, Ruthardt M, Ferrara FF, Zamir I, Seiser C, Grignani F, Lazar MA, Minucci S and Pelicci PG . (1998). Nature, 391, 815–818.

  • Grisolano JL, Wesselschmidt RL, Pelicci PG and Ley TJ . (1997). Blood, 89, 376–387.

  • Guernsey DL and Yen A . (1988). Int. J. Cancer, 42, 576–581.

  • Hayashi K, Yokozaki H, Goodison S, Oue N, Suzuki T, Lotan R, Yasui W and Tahara E . (2001). Differentiation, 68, 13–21.

  • He LZ, Guidez F, Tribioli C, Peruzzi D, Ruthardt M, Zelent A and Pandolfi PP . (1998). Nat. Genet., 18, 126–135.

  • He LZ, Tolentino T, Grayson P, Zhong S, Warrell Jr RP, Rifkind RA, Marks PA, Richon VM and Pandolfi PP . (2001). J. Clin. Invest., 108, 1321–1330.

  • He LZ, Tribioli C, Rivi R, Peruzzi D, Pelicci PG, Soares V, Cattoretti G and Pandolfi PP . (1997). Proc. Natl. Acad. Sci. USA, 94, 5302–5307.

  • Heald P . (2000). Clin. Lymphoma Suppl., 1, S45–S49.

  • Hong WK and Itri LM . (1994). The Retinoids: Biology, Chemistry and Medicine. Sporn MB, Roberts AB and Goodman DS (eds), 2nd edn. Raven Press: New York, pp. 597–630.

    Google Scholar 

  • Hong WK and Sporn MB . (1997). Science, 278, 1073–1077.

  • Horlein AJ, Naar AM, Heinzel T, Torchia J, Gloss B, Kurokawa R, Ryan A, Kamei Y, Soderstrom M, Glass CK and Rosenfeld MG . (1995). Nature, 377, 397–404.

  • Houldsworth J, Heath SC, Bosl GJ, Studer L and Chaganti RS . (2002). Cell Growth Differ., 13, 257–264.

  • Houle B, Rochette-Egly C and Bradley WE . (1993). Proc. Natl. Acad. Sci. USA, 90, 985–989.

  • Ivanova T, Petrenko A, Gritsko T, Vinokourova S, Eshilev E, Kobzeva V, Kisseljov F and Kisseljova N . (2002). BMC Cancer, 2, 4.

  • Johnstone RW . (2002). Nat. Rev. Drug Discov., 1, 287–299.

  • Karpf AR and Jones DA . (2002). Oncogene, 21, 5496–5503.

  • Khuri FR and Lippman SM . (2000). Semin. Surg. Oncol., 18, 100–105.

  • Kitareewan S, Pitha-Rowe I, Ma Y, Freemantle SJ and Dmitrovsky E . (2003). The Retinoids and Cancer Prevention Mechanisms. Vol. 1: Promising Cancer Chemopreventive Agents. Kelloff GJ, Hawk ET and Sigman CC (eds). Humana Press: New Jersey (in press).

  • Kitareewan S, Pitha-Rowe I, Sekula D, Lowrey CH, Nemeth MJ, Golub TR, Freemantle SJ and Dmitrovsky E . (2002). Proc. Natl. Acad. Sci. USA, 99, 3806–3811.

  • Kitareewan S, Spinella MJ, Allopenna J, Reczek PR and Dmitrovsky E . (1999). Oncogene, 18, 5747–5755.

  • Kizaki M, Ueno H, Yamazoe Y, Shimada M, Takayama N, Muto A, Matsushita H, Nakajima H, Morikawa M, Koeffler HP and Ikeda Y . (1996). Blood, 87, 725–733.

  • Kwong J, Lo KW, To KF, Teo PM, Johnson PJ and Huang DP . (2002). Clin. Cancer Res., 8, 131–137.

  • Lampron C, Rochette-Egly C, Gorry P, Dolle P, Mark M, Lufkin T, LeMeur M and Chambon P . (1995). Development, 121, 539–548.

  • Lemon B, Inouye C, King DS and Tjian R . (2001). Nature, 414, 924–928.

  • Li YP, Said F and Gallagher RE . (1994). Blood, 83, 3298–3302.

  • Lian Z, Wang L, Yamaga S, Bonds W, Beazer-Barclay Y, Kluger Y, Gerstein M, Newburger PE, Berliner N and Weissman SM . (2001). Blood, 98, 513–524.

  • Licht JD . (2001). Oncogene, 20, 5660–5679.

  • Lin RJ and Evans RM . (2000). Mol. Cell, 5, 821–830.

  • Lin RJ, Nagy L, Inoue S, Shao W, Miller Jr WH and Evans RM . (1998). Nature, 391, 811–814.

  • Lippman SM, Lee JJ, Karp DD, Vokes EE, Benner SE, Goodman GE, Khuri FR, Marks R, Winn RJ, Fry W, Graziano SL, Gandara DR, Okawara G, Woodhouse CL, Williams B, Perez C, Kim HW, Lotan R, Roth JA and Hong WK . (2001). J. Natl. Cancer Inst., 93, 605–618.

  • Lippman SM, Shin DM, Lee JJ, Batsakis JG, Lotan R, Tainsky MA, Hittelman WN and Hong WK . (1995). Cancer Res., 55, 16–19.

  • Lotan R, Xu XC, Lippman SM, Ro JY, Lee JS, Lee JJ and Hong WK . (1995). N. Engl. J. Med., 332, 1405–1410.

  • Lubbert M . (2000). Curr. Top. Microbiol. Immunol., 249, 135–164.

  • Matsushita H, Kizaki M, Kobayashi H, Ueno H, Muto A, Takayama N, Awaya N, Kinjo K, Hattori Y and Ikeda Y . (1998). Blood, 91, 2452–2458.

  • Maurer BJ, Melton L, Billups C, Cabot MC and Reynolds CP . (2000). J. Natl. Cancer Inst., 92, 1897–1909.

  • McCaffery P and Drager UC . (2000). Cytokine Growth Factor Rev., 11, 233–249.

  • Melnick A and Licht JD . (1999). Blood, 93, 3167–3215.

  • Milutinovic S, Knox JD and Szyf M . (2000). J. Biol. Chem., 275, 6353–6359.

  • Miller Jr WH, Moy D, Li A, Grippo JF and Dmitrovsky E . (1990). Oncogene, 5, 511–517.

  • Moasser MM, DeBlasio A and Dmitrovsky E . (1994). Oncogene, 9, 833–840.

  • Moghal N and Neel BG . (1995). Mol. Cell. Biol., 15, 3945–3959.

  • Moon RC, Mehta RG and Rao KVN . (1994). The Retinoids: Biology, Chemistry, and Medicine. Sporn MB, Roberts AB and Goodman DS (eds), 2nd edn. Raven Press: New York, pp. 573–595.

    Google Scholar 

  • Moore DM, Kalvakolanu DV, Lippman SM, Kavanagh JJ, Hong WK, Borden EC, Paredes-Espinoza M and Krakoff IH . (1994). Semin. Hematol., 31 (Suppl. 5), 31–37.

  • Mori J, Suzuki S, Hara M, Kaneko A, Yamashita K, Kumagai M, Sakuma T, Kakizawa T, Yamazaki M, Takeda T, Miyamoto T, Ichikawa K and Hashizume K . (1999). Jpn. J. Cancer Res., 90, 660–668.

  • Naar AM, Lemon BD and Tjian R . (2001). Annu. Rev. Biochem., 70, 475–501.

  • Nakayama T, Watanabe M, Yamanaka M, Hirokawa Y, Suzuki H, Ito H, Yatani R and Shiraishi T . (2001). Lab. Invest., 81, 1049–1057.

  • Nason-Burchenal K and Dmitrovsky E . (1996). Molecular Biology of Cancer. Bertino JR (ed). 1st edn Academic Press: San Diego, pp. 1547–1560.

    Google Scholar 

  • Nason-Burchenal K and Dmitrovsky E . (1999). Retinoids: Handbook of Experimental Pharmacology. Nau H and Blaner WS (eds), Vol. 139. Springer: Berlin, pp. 301–322.

    Book  Google Scholar 

  • Nason-Burchenal K, Maerz W, Albanell J, Allopenna J, Martin P, Moore MA and Dmitrovsky E . (1997). Differentiation, 61, 321–331.

  • Nason-Burchenal K, Takle G, Pace U, Flynn S, Allopenna J, Martin P, George ST, Goldberg AR and Dmitrovsky E . (1998). Oncogene, 17, 1759–1768.

  • Nehme A, Varadarajan P, Sellakumar G, Gerhold M, Niedner H, Zhang Q, Lin X and Christen RD . (2001). Br. J. Cancer, 84, 1571–1576.

  • Nervi C, Ferrara FF, Fanelli M, Rippo MR, Tomassini B, Ferrucci PF, Ruthardt M, Gelmetti V, Gambacorti-Passerini C, Diverio D, Grignani F, Pelicci PG and Testi R . (1998). Blood, 92, 2244–2251.

  • Njar VC . (2002). Mini. Rev. Med. Chem., 2, 261–269.

  • Nowfar S, Teplitzky SR, Melancon K, Kiefer TL, Cheng Q, Dwived PD, Bischoff ED, Moro K, Anderson MB, Dai J, Lai L, Yuan L and Hill SM . (2002). Breast Cancer Res. Treat., 72, 33–43.

  • Ozpolat B and Lopez-Berestein G . (2002). Leuk. Lymphoma, 43, 933–941.

  • Ozpolat B, Lopez-Berestein G and Mehta K . (2001). J. Biol. Regul. Homeost. Agents, 15, 107–122.

  • Paietta E, Andersen J, Racevskis J, Gallagher R, Bennett J, Yunis J, Cassileth P and Wiernik PH . (1994). Leukemia, 8, 968–973.

  • Palmisano WA, Divine KK, Saccomanno G, Gilliland FD, Baylin SB, Herman JG and Belinsky SA . (2000). Cancer Res., 60, 5954–5958.

  • Pandolfi PP . (2001). Oncogene, 20, 3116–3127.

  • Pendino F, Sahraoui T, Lanotte M and Segal-Bendirdjian E . (2002). Leukemia, 16, 826–832.

  • Petti MC, Fazi F, Gentile M, Diverio D, De Fabritiis P, De Propris MS, Fiorini R, Spiriti MA, Padula F, Pelicci PG, Nervi C and Lo Coco F . (2002). Blood, 100, 1065–1067.

  • Piazza F, Gurrieri C and Pandolfi PP . (2001). Oncogene, 20, 7216–7222.

  • Picard E, Seguin C, Monhoven N, Rochette-Egly C, Siat J, Borrelly J, Martinet Y, Martinet N and Vignaud JM . (1999). J. Natl. Cancer Inst., 91, 1059–1066.

  • Piedrafita FJ and Pfahl M . (1999). Handb. Exp. Pharm., 139, 153–184.

  • Privalsky ML . (2001). Curr. Top. Microbiol. Immunol., 254, 117–136.

  • Qiu H, Zhang W, El-Naggar AK, Lippman SM, Lin P, Lotan R and Xu XC . (1999). Am. J. Pathol., 155, 1519–1523.

  • Rachez C and Freedman LP . (2001). Curr. Opin. Cell Biol., 13, 274–280.

  • Rachez C, Lemon BD, Suldan Z, Bromleigh V, Gamble M, Naar AM, Erdjument-Bromage H, Tempst P and Freedman LP . (1999). Nature, 398, 824–828.

  • Rastinejad F . (2001). Curr. Opin. Struct. Biol., 11, 33–38.

  • Reid GK, Besterman JM and MacLeod AR . (2002). Curr. Opin. Mol. Ther., 4, 130–137.

  • Reynolds CP and Lemons RS . (2001). Hematol. Oncol. Clin. North Am., 15, 867–910.

  • Reynolds CP, Wang Y, Melton LJ, Einhorn PA, Slamon DJ and Maurer BJ . (2000). Med. Pediatr. Oncol., 35, 597–602.

  • Robert MF, Morin S, Beaulieu N, Gauthier F, Chute IC, Barsalou A and MacLeod AR . (2003). Nat. Genet., 33, 61–65.

  • Robertson KA, Emami B and Collins SJ . (1992). Blood, 80, 1885–1889.

  • Rosenfeld MG and Glass CK . (2001). J. Biol. Chem., 276, 36865–36868.

  • Shao W, Benedetti L, Lamph WW, Nervi C and Miller Jr WH . (1997). Blood, 89, 4282–4289.

  • Si SP, Lee X, Tsou HC, Buchsbaum R, Tibaduiza E and Peacocke M . (1996). Exp. Cell. Res., 223, 102–111.

  • Silverman LR, Demakos EP, Peterson BL, Kornblith AB, Holland JC, Odchimar-Reissig R, Stone RM, Nelson D, Powell BL, DeCastro CM, Ellerton J, Larson RA, Schiffer CA and Holland JF . (2002). J. Clin. Oncol., 20, 2429–2440.

  • Sirchia SM, Ren M, Pili R, Sironi E, Somenzi G, Ghidoni R, Toma S, Nicolo G and Sacchi N . (2002). Cancer Res., 62, 2455–2461.

  • Slack JL . (1999). Curr. Opin. Oncol., 11, 9–13.

  • Spinella MJ, Kitareewan S, Mellado B, Sekula D, Khoo KS and Dmitrovsky E . (1998). Oncogene, 16, 3471–3480.

  • Suh N, Lamph WW, Glasebrook AL, Grese TA, Palkowitz AD, Williams CR, Risingsong R, Farris MR, Heyman RA and Sporn MB . (2002a). Clin. Cancer Res., 8, 3270–3275.

  • Suh YA, Lee HY, Virmani A, Wong J, Mann KK, Miller Jr WH, Gazdar A and Kurie JM . (2002b). Cancer Res., 62, 3945–3949.

  • Sun SY and Lotan R . (2002). Crit. Rev. Oncol. Hematol., 41, 41–55.

  • Takeshita A, Shinjo K, Naito K, Ohnishi K, Sugimoto Y, Yamakawa Y, Tanimoto M, Kitamura K, Naoe T and Ohno R . (2000). Br. J. Haematol., 108, 90–92.

  • Tallman MS and Nabhan C . (2002). Curr. Oncol. Rep., 4, 381–389.

  • Tamayo P, Slonim D, Mesirov J, Zhu Q, Kitareewan S, Dmitrovsky E, Lander ES and Golub TR . (1999). Proc. Natl. Acad. Sci. USA, 96, 2907–2912.

  • Testa U, Grignani F, Barberi T, Fagioli M, Masciulli R, Ferrucci PF, Seripa D, Camagna A, Alcalay M, Pelicci PG and Peschle C . (1994). Cancer Res., 54, 4508–4515.

  • Torrisi R and Decensi A . (2000). Curr. Oncol. Rep., 2, 263–270.

  • Toulouse A, Morin J, Dion PA, Houle B and Bradley WE . (2000). Lung Cancer, 28, 127–137.

  • Urnov FD, Wolffe AP and Guschin D . (2001). Curr. Top. Microbiol. Immunol., 254, 1–33.

  • van der Burg B, van der Leede BM, Kwakkenbos-Isbrucker L, Salverda S, de Laat SW and van der Saag PT . (1993). Mol. Cell. Endocrinol., 91, 149–157.

  • Van Heusden J, Van Ginckel R, Bruwiere H, Moelans P, Janssen B, Floren W, van der Leede BJ, van Dun J, Sanz G, Venet M, Dillen L, Van Hove C, Willemsens G, Janicot M and Wouters W . (2002). Br. J. Cancer, 86, 605–611.

  • Virmani AK, Rathi A, Zochbauer-Muller S, Sacchi N, Fukuyama Y, Bryant D, Maitra A, Heda S, Fong KM, Thunnissen F, Minna JD and Gazdar AF . (2000). J. Natl. Cancer. Inst., 92, 1303–1307.

  • Wallberg AE, Neely KE, Hassan AH, Gustafsson JA, Workman JL and Wright AP . (2000). Mol. Cell Biol., 20, 2004–2013.

  • Wang DL, Marko M, Dahl AR, Engelke KS, Placke ME, Imondi AR, Mulshine JL and De Luca LM . (2000). Clin. Cancer Res., 6, 3636–3645.

  • Warrell Jr RP . (1993). Blood, 82, 1949–1953.

  • White JA, Beckett-Jones B, Guo YD, Dilworth FJ, Bonasoro J, Jones G and Petkovich M . (1997). J. Biol. Chem., 272, 18538–18541.

  • Widschwendter M, Berger J, Daxenbichler G, Muller-Holzner E, Widschwendter A, Mayr A, Marth C and Zeimet AG . (1997). Cancer Res., 57, 4158–4161.

  • Widschwendter M, Berger J, Hermann M, Muller HM, Amberger A, Zeschnigk M, Widschwendter A, Abendstein B, Zeimet AG, Daxenbichler G and Marth C . (2000). J. Natl. Cancer Inst., 92, 826–832.

  • Wolbach BS and Howe PR . (1925). J. Exp. Med., 42, 753–777.

  • Wu Q, Li Y, Liu R, Agadir A, Lee MO, Liu Y and Zhang X . (1997). EMBO J., 16, 1656–1669.

  • Xu L, Glass CK and Rosenfeld MG . (1999). Curr. Opin. Genet. Dev., 9, 140–147.

  • Xu W, Chen H, Du K, Asahara H, Tini M, Emerson BM, Montminy M and Evans RM . (2001). Science, 294, 2507–2511.

  • Xu XC, Ro JY, Lee JS, Shin DM, Hong WK and Lotan R . (1994). Cancer Res., 54, 3580–3587.

  • Xu XC, Sozzi G, Lee JS, Lee JJ, Pastorino U, Pilotti S, Kurie JM, Hong WK and Lotan R . (1997a). J. Natl. Cancer Inst., 89, 624–629.

  • Xu XC, Sneige N, Liu X, Nandagiri R, Lee JJ, Lukmanji F, Hortobagyi G, Lippman SM, Dhingra K and Lotan R . (1997b). Cancer Res., 57, 4992–4996.

  • Yoshida H, Kitamura K, Tanaka K, Omura S, Miyazaki T, Hachiya T, Ohno R and Naoe T . (1996). Cancer Res., 56, 2945–2948.

  • Zelent A, Guidez F, Melnick A, Waxman S and Licht JD . (2001). Oncogene, 20, 7186–7203.

  • Zhou DC, Hallam SJ, Lee SJ, Klein RS, Wiernik PH, Tallman MS and Gallagher RE . (1998). Cancer Res., 58, 5770–5776.

  • Zhou DC, Kim SH, Ding W, Schultz C, Warrell Jr RP and Gallagher RE . (2002). Blood, 99, 1356–1363.

  • Zujewski J . (2002). Environ. Mol. Mutagen., 39, 264–270.

Download references

Acknowledgements

We thank Ms Katey Krizan (Dartmouth College) for critical reading of this manuscript. This work was supported by grants from the Lance Armstrong Foundation (SJF) and the Hitchcock Foundation (SJF). This work was also supported by National Institutes of Health (NIH) Grants R01-CA87546 (ED), R01-CA62275 (ED), and K01-CA75154-01 (MJS), as well as the American Cancer Society Research Scholar Grant RSG-01-144-01 (MJS), the Samual Waxman Cancer Research Foundation Award (ED), and the Oracle Giving Fund (ED).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sarah J Freemantle.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Freemantle, S., Spinella, M. & Dmitrovsky, E. Retinoids in cancer therapy and chemoprevention: promise meets resistance. Oncogene 22, 7305–7315 (2003). https://doi.org/10.1038/sj.onc.1206936

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1206936

Keywords

This article is cited by

Search

Quick links